Portfolio company
Apexian Pharmaceuticals
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops oral small molecule drugs targeting specific proteins to treat patients with cancer and inflammatory bowel diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Apoxis SA
This company develops therapeutic proteins and small molecules for the treatment of cancer and inflammatory diseases in clinical-stage patients.
Auron Therapeutics
This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.
Pharmacyclics
This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.
BlossomHill Therapeutics
This biopharmaceutical company develops small molecule medicines to treat patients with various forms of cancer and autoimmune disorders.
Biopharmaceutical company
This firm develops small molecule drugs targeting protein regulatory sites to treat patients with cancer and autoimmune diseases.
Accent Therapeutics
This biopharmaceutical company develops small molecule precision therapies for patients with various types of cancer.
Peloton Therapeutics
This biopharmaceutical company develops small molecule oral medicines for patients with renal cell carcinoma and other forms of cancer.
Frontier Medicines
This biopharmaceutical company develops small-molecule precision medicines targeting undruggable proteins for patients with cancer and immunological diseases.